National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 1,726 cases where Vaccine targets Shingles (VARZOS) and Disabled and Vaccination Date on/before '2019-05-31'

Table

   
AgeCountPercent
17-44 Years40.23%
44-65 Years30517.67%
65-75 Years31218.08%
75+ Years20511.88%
Unknown90052.14%
TOTAL1,726100%

Case Details

This is page 1 out of 173

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 261665 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Male  
Location: Michigan  
Vaccinated:2006-07-11
Onset:2006-07-27
   Days after vaccination:16
Submitted: 2006-08-14
   Days after onset:18
Entered: 2006-08-17
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Dyspnoea, Heart rate increased, Nervousness, Tachycardia
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Zetia
Current Illness:
Preexisting Conditions: Hypercholesterolaemia, Joint disorder
Allergies:
Diagnostic Lab Data: Electrocardiogram 7/27/06 HR 110-120
CDC Split Type: WAES0608USA01046

Write-up: Information has been received from a 71 year old retired physician with no known allergies and hypercholesterolaemia who on 7/11/06 was vaccinated in the left arm with a dose of varicella zoster virus vaccine live. Concomitant therapy included ezetimibe. A couple weeks after vaccination on 7/27/06, the pt experienced tachycardia that was persisted. He was seen by a two cardiologists and had an echocardiogram done which did not show anything. Two EKGs were done and his HR was 110-120. He also reported that he was having a little shortness of breath occasionally,but didn''t think, it was related to vaccination. He did not have any other cardiovascular problems. The physician reported his sustained tachycardia to be potentially life threatening and disabling because he wasn''t sure if his tachycardia was self limiting and temporary or would cause additional problems. He reported that he was nervous when his HR was high for 2-3 weeks. His cardiologist recommended unspecified medication, however the physician refused to take any medication. As of 8/10/06 the physician reported that his heartrate was gradually slowing down, it was 90-100 which was better than before but still not back to normal. Four months prior to vaccination the pt scheduled knee surgery for 8/22/06. He explained that he would proceed with the surgery as long as his heart rate was back to normal. Additional information has been requested.


VAERS ID: 266811 (history)  
Form: Version 1.0  
Age: 88.0  
Sex: Female  
Location: Illinois  
Vaccinated:2006-09-06
Onset:2006-10-16
   Days after vaccination:40
Submitted: 2006-11-10
   Days after onset:25
Entered: 2006-11-15
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK RA / SC

Administered by: Other       Purchased by: Other
Symptoms: Back pain, Condition aggravated, Pain, Sleep disorder
SMQs:, Retroperitoneal fibrosis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Tylenol, Allopurinol, aspirin, Carbatrol, Furosemide, Synthroid, Zocor, Spironolactone.
Current Illness:
Preexisting Conditions: Upper extremity mass, mass excision, gout, skin cancer, cellulitis, heart attack, cholelithiasis, Arthritis, coronary artery disease, shingles, cholesterol levels raised.
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0611USA00187

Write-up: Information has been received from a medical assistant and an 89 year old female consumer with arthritis, increased cholesterol levels, coronary artery disease and shingles. since 9/28/1992 and a history of a mass in the right hand with surgery, gout, skin cancer on her face in 1984, cellulitis, cholelithiasis in 1978 and a heart attack in 1988 and 1989, she had angiogram in 1990 and a 30% double vessel occlusion. On 9/6/06 was vaccinated SC in the right arm with a dose of Varicella zoster virus vaccine live. There was no concomitant vaccinations. Concomitant therapy included Carbatrol, Allopurinol, Synthroid, Simvastatin, Spironolactone, aspirin and Tylenol. The pt thought that one shot of the vaccine would cure her shingles. It was noted that the pt was not experiencing pain from the injection site. the medical assistant also stated that the pt had pain from a previous shingles experience, however, the pain is reportedly worse since receiving the vaccine. The pt was worse later in the day and has interrupted the pts ability to sleep at night. It was reported that the pt did not experienced a rash. The pt had reported that she was previously seen by a neurologist, had acupuncture but nothing works for her shingles. About 3 weeks ago, on approx 10/16/06, the pt was experiencing severe pain in her back area after receiving varicella zoster virus vaccine live. At the time of this report, the pt had not recovered. It was reported that the pts experienced were disabling. Additional information has been requested.


VAERS ID: 269643 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2006-12-01
Onset:2006-12-04
   Days after vaccination:3
Submitted: 2006-12-20
   Days after onset:16
Entered: 2006-12-27
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abasia, Hypoaesthesia, Pyrexia
SMQs:, Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, 12?/??/2006, "blood work," results not reported; body temp, 12?/??/2006, 100 degrees.
CDC Split Type: WAES0612USA02676

Write-up: Information has been received from a physician concerning an "over 60" year old female who in approximately December 2006, was vaccinated with a dose of ZOSTAVAX. Subsequently, 3-4 days after receiving ZOSTAVAX the patient developed numbness in her legs, lips and around her mouth, and a fever. The patient "could not walk" due to this event. The patient was referred to a neurologist to rule out Guillain-Barre Syndrome. The patient was also referred to an infectious disease specialist to determine if the event was vaccine related. At the time of the report the patient''s numbness had improved but she was still spiking a temperature of 100-101 degrees. Unspecified "blood work" was performed. The patient was discharged from the hospital after 11 days as an inpatient. There was no product quality complaint involved. No additional information was available. The reporter considered the patient''s events to be disabling and serious for hospitalization. Additional information has been requested.


VAERS ID: 271484 (history)  
Form: Version 1.0  
Age: 77.0  
Sex: Female  
Location: Unknown  
Vaccinated:2006-12-01
Onset:2006-12-01
   Days after vaccination:0
Submitted: 2007-01-29
   Days after onset:59
Entered: 2007-01-30
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1406F / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Sciatica
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOSAMAX, calcium (unspecified) CELEBREX
Current Illness:
Preexisting Conditions: Finger arthritis, Osteopenia
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0701USA02176

Write-up: Information has been received from a physician concerning her 77 year old mother with a arthritis in her finger, osteopenia and no known drug allergies who in December 2006 was vaccinated SC with a 0.5 ml dose of Zostavax vaccine. Concomitant therapy included Celebrex, alendronate sodium and calcium (unspecified). Subsequently four to six days after vaccination, in December 2006, the patient developed sciatica. She was treated with oral steroids. As of 25-Jan-2007 the patient was recovering. The physician reported that her mother was still having some problems and was going to physical therapy. She explained that prior to vaccination, her mother was very healthy and active and exercised on a regular basis. It was noted that the patient had no rash. The physician considered the sciatica to be disabling and an other important medical event. Additional information has been requested.


VAERS ID: 272951 (history)  
Form: Version 1.0  
Age: 73.0  
Sex: Female  
Location: Unknown  
Vaccinated:2006-11-22
Onset:2006-11-23
   Days after vaccination:1
Submitted: 2007-02-22
   Days after onset:91
Entered: 2007-02-23
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Bedridden, Blister, Condition aggravated, Herpes zoster, Influenza like illness, Malaise, Nerve injury, Pneumonia viral, Pruritus, Rash
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Accidents and injuries (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma, Gout
Preexisting Conditions: Shingles
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0702USA02903

Write-up: Information has been received from a 73 year old female consumer with asthma (diagnosed in 1971), gout (for the past four years since approximately 2003) and a history of shingles who on 22-NOV-2006 was vaccinated with a dose of Varivax. It was reported that the patient''s initial bout with shingles "two years ago" was "very painful and unnerving for her." The patient had a few less painful rounds with it since that initial one, with small blisters on her hip and thigh. In October 2006 the patient "had another bad case" and was treated with acyclovir. The patient reported that she was back in the office on 22-NOV-2006 for a follow up and prescription refill. The nurse practitioner reportedly told the patient about this new wonder drug that would wipe out her shingles. The patient stated that the nurse practitioner "convinced her" by assuring her that she had both of her parents inoculated against shingles the week before. The patient allowed the nurse practitioner to give her the shot that day. The following morning, on 23-NOV-2006, the patient woke with what she thought was the flu, so sick that she wanted to die. In the next few days she really thought that she was "was going to die." The patient reported that she has had shingles since that day and that they settled on her spine next to her tailbone and that she had blisters under the skin that constantly itch. The patient developed small, scaly, itchy patches on her legs and arms that "will not go away.". The patient was using triamcinolone Acetonide USP 0.1% ointment which would dry them partially but they would return the next day. At the time of reporting the patient was on Sulfam + Tri Tab O.Bs, and prednisone 10 mg daily from what her physician diagnosed s viral pneumonia caused by the shingles. The patient reported that she was bedridden for 10 days (considered disabling). The patient states that she "cannot take this any longer" and that her doctor tells her that her nerve endings are damaged along her spine. Her doctor has prescribed her Cymbalta but she states that she is "afraid to take any more meds from this doctor." She is "afraid of the side effects." The patient states that the vaccine "nearly killed me, and I''m not sure it won''t before I''m cured of it - or rather IF I''m ever cured." Additional information has been requested.


VAERS ID: 273024 (history)  
Form: Version 1.0  
Age: 73.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2006-11-20
Onset:2006-11-20
   Days after vaccination:0
Submitted: 2007-02-23
   Days after onset:95
Entered: 2007-02-26
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1012F / UNK - / SC

Administered by: Other       Purchased by: Other
Symptoms: Herpes zoster, Incorrect dose administered, Lymphadenectomy, Oedema, Skin lesion, Varicella zoster virus serology positive
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Breast cancer; Lymphadenectomy
Allergies:
Diagnostic Lab Data: diagnostic laboratory - positive VZ 1GG
CDC Split Type: WAES0702USA01797

Write-up: Information has been received from a physician concerning a 73 year old female with a history of breast cancer and lymphadenectomy who on 20-NOV-2006 was vaccinated SC with a 0.5ml dose of Zostavax (lot #652946/1012F). On 25-JAN-2007 the patient developed shingles. The patient has symptoms of herpes zoster 5-7 days prior to being seen. The patient also developed some edema near the lesions. The patient was seen by the physician and was treated with Valcyclovir. It was reported that the patient has had the herpes zoster in the dermatone of the lymphadenectomy and had a prolonged recovery. As of 13-FEB-2007 she may still have active lesions and was recovering. There was no product quality complaint involved. The patient''s shingles and edema were considered to be disabling. Additional information has been requested.


VAERS ID: 273178 (history)  
Form: Version 1.0  
Age: 78.0  
Sex: Male  
Location: New York  
Vaccinated:2007-01-20
Onset:2007-02-01
   Days after vaccination:12
Submitted: 2007-02-27
   Days after onset:26
Entered: 2007-02-28
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Balance disorder, Confusional state, Dementia, Fall, Hallucination, Head injury, Insomnia, Nuclear magnetic resonance imaging
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (narrow), Psychosis and psychotic disorders (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Therapy unspecified, Sinemet, Neurotin
Current Illness: Drug hypersensitivity, Parkinson''s disease, Neuropathy peripheral.
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Magnetic resonance 02/01/07 results not provided.
CDC Split Type: WAES0702USA04042

Write-up: Information has been received from a registered nurse concerning her 78 year old father with an allergy to AMBIEN, Parkinson''s disease, and peripheral neuropathy who on 20-JAN-2007 was vaccinated with a dose of Varivax. Concomitant therapy included Carbidopa - levodopa (manufacturer unknown), an unspecified blood pressure medication, and NEURONTIN. The patient has had Parkinson''s disease for seven years and a day after the vaccination, on 01-FEB-2007, he seemed off balance and confused. On 07-FEB-2007, he was falling numerous times and profoundly confused. He needed full time care and he fell on his head many times. He "cannot be left alone for a minute." He was noted to be up all night and walking and hallucinating. He went to a neurologist and was diagnosed with Lewy body disease. An MRI was performed (results not provided). At the time of the report, the patient had not recovered. A product quality complaint was not involved. The Patient''s experiences were considered to be disabling by the reporter. No further information is available.


VAERS ID: 273182 (history)  
Form: Version 1.0  
Age: 74.0  
Sex: Male  
Location: Florida  
Vaccinated:2006-12-27
Onset:2007-01-15
   Days after vaccination:19
Submitted: 2007-02-23
   Days after onset:39
Entered: 2007-02-28
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1406F / 1 - / IM

Administered by: Public       Purchased by: Private
Symptoms: Biopsy, Blister, Carpal tunnel syndrome, Hypoaesthesia, Pruritus, Rash, Transient acantholytic dermatosis
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cozaar, ASA, Imdur, Toprol, Lipitor
Current Illness: NONE
Preexisting Conditions: Penicillin allergy, aortic aneurysm, coronary artery disease.
Allergies:
Diagnostic Lab Data: biopsy 2/8/07, focal ancotholytic, dyskeratosis records received 4/11/07-Dermatology path report 12/14/07 prior to vaccine consistent with actinic keratosis. Some thermal artifact. Squamous cell carcinoma in situ.
CDC Split Type:

Write-up: Poison ivy like rash started on Hands and arms 2-3 weeks following administration of vaccine treated with cortisone 1% ointment. Arms and hands healed and rash moved to lower back with severe itching and blistering. Biopsy done 2/8 diagnosis is Grover''s disease. 04/11/07-records received. DX early cellulitis. questionable vaccine fever. Per annual follow up report: Product should be labeled: Risk of systemic herpes zoster reaction. Follow-up: During recovery carpal tunnel syndrome developed in the dominant hand (right), may or may not be related? Otherwise patient is fully recovered. Cortisone injections into the tunnel have reduced numbness slightly.


VAERS ID: 273515 (history)  
Form: Version 1.0  
Age: 91.0  
Sex: Female  
Location: Tennessee  
Vaccinated:2007-02-08
Onset:2007-02-21
   Days after vaccination:13
Submitted: 2007-03-06
   Days after onset:13
Entered: 2007-03-07
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1477F / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Back pain, Herpes zoster, Pain
SMQs:, Retroperitoneal fibrosis (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: Latex allergy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0702USA03937

Write-up: Information has been received from a pharmacist concerning a 91 year old female with a latex allergy who on 08-FEB-2007 was vaccinated SC with a 0.65 ml dose of Zostavax (lot #656413/1477F). There was no concomitant medication. On 21-FEB-2007 the patient experienced experienced pain in her side and back and was diagnosed with shingles. Another pharmacist reported that the patient stated she was in severe pain and insisted her shingles were from the vaccine. The pharmacist did not know the number of lesions. No laboratory tests were performed. At the time of the report, the patient had not recovered. The patient never had any adverse experiences with other vaccines in the past. Shingles was considered to be disabling. Additional information has been requested.


VAERS ID: 275039 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: Colorado  
Vaccinated:2006-12-12
Onset:2006-12-28
   Days after vaccination:16
Submitted: 2007-07-11
   Days after onset:194
Entered: 2007-03-16
   Days after submission:117
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / 1 UN / SC

Administered by: Private       Purchased by: Private
Symptoms: Computerised tomogram head, Ear, nose and throat examination, Facial pain, Headache, Hypoacusis, Nervous system disorder, Scan brain, Tinnitus
SMQs:, Glaucoma (broad), Hearing impairment (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: (therapy unspecified); FIORICET TABLETS; FOSAMAX; desipramine hydrochloride; COZAAR; TOPROL XL TABLETS; niacin; MAXALT (RIZATRIPTAN BENZOATE)
Current Illness: Migraine; Hypertension; Osteopenia; Cataract; Cystitis interstitial; Neck pain
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: ears, nose, and throat 01/??/07 - see narr.; head computed axial 01/??/07 - sinuses/brain: no significant abnormalities
CDC Split Type: WAES0702USA01800

Write-up: Information has been received from a consumer concerning his 60 year old wife who on 12-DEC-2006 was vaccinated with a dose of Zostavax. On 30-DEC-2006 the patient was diagnosed with symptoms of a "typical nerve disorder". Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/14/2007; 6/22/2007; 7/5/2007. Information has been received from a reporter concerning his 60 year old caucasion wife with no drug allergies, migraine (on the right side for 40 years), hypertension, osteopenis, cataracts, and interstitial cystitis who on 12-DEC-2006 at approximately 09:00 was vaccinated SC in the left deltoid with a first dose of varicella-zoster virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. Concomitant therapy included losartan potassium (MSD), TOPROL XL TABLETS, desipramine HC1, alendronate sodium (MSD), rizatriptan benzoate (MSD), niacin, FIORICHT TABLETS and "Elmira." On 30-DEC-2006, the patient was diagnosed with symptoms of a "typical nerve disorder." Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been received from the patient''s neurologist, including medical records. The neurologist noted that he was consulted only and did not get the vaccine. The patient was seen on 06-FEB-2007 by the neurologist for the chief complaint of left facial pain. The symptoms began on 28-DEC-2006. She started to notice pain around the left temple and periorbital region on the left. The pain could become very intense and have a duration of several hours. It was a constant pain most of the time with occasional sharp pains. There was no associated change in vision or speech. There was no swelling of the eye or redness and no change in the nasal drainage or congestion. She did get associated roaring tinnitus, mostly in the left ear, in association with the acute pain episodes. Her hearing was diminished during these episodes only. There may also have been some left posterior neck pain. The neck pain had been a recurrent issue for many years. She found that coughing or sneezing would exacerbate symptoms. She usually felt better when she was supine. She was treated with several courses of antibiotics without any improvement. After an ENT evaluation, it was felt that the problems were not related to the sinuses and most likely were neurologic, prompting the consult. She had CT scans of the sinuses and brain with no significant abnormalities. The impression was atypical facial pain most likely representing a variation of trigeminal cephalgia. The distribution was predominantly V1. The precise precipitating factor was not clear. Her examination was unremarkable and negative imaging with CT scan ws reassuring for no masses or other serious intracranial pathology. The plan included a trial of LYRICA and indomethacin and to be followed-up in one month. A follow-up visit was done on 23-FEB-2007. She presented with atypical facial pain and unusual form of tinnitus. Since taking the LYRICA, the pain was 90 percent controlled. However, she stated that the roaring sound in the ear persisted and was very bothersome. She was an ENT who had no specific explaination for the symptoms. He recommended a low salt diet and a diuretic. She was already using MAXIDE. Her hearing is normal. The impression was that her pain was much improved with LYRICA but persistence of roaring sensation in the head. The mechanism remained elusive as did the cause. The plan included trying cyclobenzaprine hydrochloride (MSD) 10 mgs as needed. She would continue the LYRICA 75 mg BID. The neurologist talked about looking at the cerebral vasculature with an angiogram. He was skeptical whether he would find anything treatable or even related to this. However, they might ultimately do this for completeness since a vascular malformation near the cochlea might produce a phenomenon like this. She would follow-up in one month. She was seen for a follow-up visit on 19-APR-2007. Her tinnitus had almost fully resolved. Her facial pain was well controlled. There were still intermittent pains, particularly with any form of valsalva such as coughing, laughing or sneezing. The impression was stable atypical facial pain but concerns about valsalva maneuvers including symptoms. The possibility of aneurysm or vascular anomaly was discussed. The plan included recommending a CT angiogram of the head but he would not expect it to show any abnormality. The patient would decide if she wanted to proceed with the test. The patient''s experience was considered to be disabling by the neurologist. No further information is expected. This is an amended report. The reporter was changed from a consumer to the neurologist. Follow up information was received from a physician who reported that the patient developed pain around the left eye and roaring in the ear, especially with valsalva, that was diagnosed as temporal mandibula myofascial syndrome. The patient had a CT of the brain and sinuses and visist with an ENT and a neurologist. The physician noted that the patient got ZOSTAVAX on 12-DEC-2006 and the adverse events started later in December 2006. The patient''s experience was considered to be disabling by the neurologist. No further information is expected.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX[]=VARZOS&VAXTYPES[]=Shingles&DISABLE=Yes&VAX_YEAR_HIGH=2019&VAX_MONTH_HIGH=05


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166